BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fenofibrate
,
rs7903146
,
SLC12A1
,
Metabolism of xenobiotics
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Polo-like kinase 1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Mammary gland
Spleen
Putamen
Smooth muscle
Breast tissue
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Parvovirus infection
Congenital glucose-galactose malabsorption
Peritoneal foreign body
Huntington's disease
Disease due to Trypanosomatidae
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Breast Tumor Extract
2-methylthio-ATP
Interleukin-5
microcystin RR
Gentamicin Sulfate (USP)
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SRSF2
TRNL1
FOSL2
F2RL2
FBXW7
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Pharmacological inhibition of polo like kinase 2 (PLK2) does not cause chromosomal damage or result …
Serum inducible kinase is a positive regulator of cortical dendrite development and is required for …
Role of the SNK-SPAR pathway in the development of Alzheimer's disease.
Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and m…
Impaired c-Fos and polo-like kinase 2 induction in the limbic system of fear-conditioned α-synuclein…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Sma…
A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS
A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ